Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
Rowan T. Chlebowski,Susan L. Hendrix,Robert Langer,Marcia L. Stefanick,Margery Gass,Dorothy S. Lane,Rebecca J. Rodabough,Mary Ann Gilligan,Michele G. Cyr,Cynthia A. Thomson,Janardan D. Khandekar,Helen Petrovitch,Anne McTiernan +12 more
Reads0
Chats0
TLDR
Relatively short-term combined estrogen plus progestin use increases incident breast cancers, which are diagnosed at a more advanced stage compared with placebo use, and also substantially increases the percentage of women with abnormal mammograms, a pattern which continued for the study duration.Abstract:
ContextThe Women's Health Initiative trial of combined estrogen plus progestin
was stopped early when overall health risks, including invasive breast cancer,
exceeded benefits. Outstanding issues not previously addressed include characteristics
of breast cancers observed among women using hormones and whether diagnosis
may be influenced by hormone effects on mammography.ObjectiveTo determine the relationship among estrogen plus progestin use, breast
cancer characteristics, and mammography recommendations.Design, Setting, and ParticipantsFollowing a comprehensive breast cancer risk assessment, 16 608
postmenopausal women aged 50 to 79 years with an intact uterus were randomly
assigned to receive combined conjugated equine estrogens (0.625 mg/d) plus
medroxyprogesterone acetate (2.5 mg/d) or placebo from 1993 to 1998 at 40
clinical centers. Screening mammography and clinical breast examinations were
performed at baseline and yearly thereafter.Main Outcome MeasuresBreast cancer number and characteristics, and frequency of abnormal
mammograms by estrogen plus progestin exposure.ResultsIn intent-to-treat analyses, estrogen plus progestin increased total
(245 vs 185 cases; hazard ratio [HR], 1.24; weighted P<.001)
and invasive (199 vs 150 cases; HR, 1.24; weighted P =
.003) breast cancers compared with placebo. The invasive breast cancers diagnosed
in the estrogen plus progestin group were similar in histology and grade but
were larger (mean [SD], 1.7 cm [1.1] vs 1.5 cm [0.9], respectively; P = .04) and were at more advanced stage (regional/metastatic
25.4% vs 16.0%, respectively; P = .04) compared with
those diagnosed in the placebo group. After 1 year, the percentage of women
with abnormal mammograms was substantially greater in the estrogen plus progestin
group (716 [9.4%] of 7656) compared with placebo group (398 [5.4%] of 7310; P<.001), a pattern which continued for the study duration.ConclusionsRelatively short-term combined estrogen plus progestin use increases
incident breast cancers, which are diagnosed at a more advanced stage compared
with placebo use, and also substantially increases the percentage of women
with abnormal mammograms. These results suggest estrogen plus progestin may
stimulate breast cancer growth and hinder breast cancer diagnosis.read more
Citations
More filters
Journal ArticleDOI
Breast cancer after use of estrogen plus progestin in postmenopausal women
Rowan T. Chlebowski,Lewis H. Kuller,Ross L. Prentice,Marcia L. Stefanick,JoAnn E. Manson,Margery Gass,Aaron K. Aragaki,Judith K. Ockene,Dorothy S. Lane,Gloria E. Sarto,Aleksandar Rajkovic,Robert S. Schenken,Susan L. Hendrix,Peter M. Ravdin,Thomas E. Rohan,Shagufta Yasmeen,Garnet L. Anderson +16 more
TL;DR: The increased risk of breast cancer associated with the use of estrogen plus progestin declined markedly soon after discontinuation of combined hormone therapy and was unrelated to changes in frequency of mammography.
Journal ArticleDOI
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.
TL;DR: The characterization of estrogen receptor beta brought new insight into the mechanisms underlying estrogen signaling, and the potential distinct roles of ERalpha and ERbeta expression in carcinogenesis, as suggested by experimental and clinical data are discussed in this review.
Journal ArticleDOI
Breast Tissue Composition and Susceptibility to Breast Cancer
TL;DR: An overview of selected areas of current knowledge about the relationship between breast density and susceptibility to breast cancer is provided, and the uses of breast density in risk prediction and breast cancer prevention are reviewed.
Journal ArticleDOI
Biotechnology of flavonoids and other phenylpropanoid-derived natural products. part i: chemical diversity, impacts on plant biology and human health
Filippos Ververidis,Emmanouil A. Trantas,Emmanouil A. Trantas,Carl J. Douglas,G. Vollmer,Georg Kretzschmar,Nickolas J. Panopoulos,Nickolas J. Panopoulos +7 more
TL;DR: The diversity and biosynthetic origins of phenylpropanoids and particularly of the flavonoid and stilbenoid natural products are discussed, referring on their effects on human health and physiology and their roles as plant defense and antimicrobial compounds.
Journal ArticleDOI
Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC)
Rudolf Kaaks,Franco Berrino,Timothy J. Key,Sabina Rinaldi,Laure Dossus,Carine Biessy,Giorgio Secreto,Pilar Amiano,Sheila Bingham,Heiner Boeing,H. Bas Bueno de Mesquita,Jenny Chang-Claude,Françoise Clavel-Chapelon,Agnès Fournier,Carla H. van Gils,Carlos A. González,Aurelio Barricarte Gurrea,Elena Critselis,Kay-Tee Khaw,Vittorio Krogh,Petra H. Lahmann,Gabriele Nagel,Anja Olsen,N. Charlotte Onland-Moret,Kim Overvad,Domenico Palli,Salvatore Panico,Petra H.M. Peeters,J. Ramón Quirós,Andrew W. Roddam,Anne C. M. Thiébaut,Anne Tjønneland,Ma Dolores Chirlaque,Antonia Trichopoulou,Dimitrios Trichopoulos,Rosario Tumino,Paolo Vineis,Paolo Vineis,Teresa Norat,Pietro Ferrari,Nadia Slimani,Elio Riboli +41 more
TL;DR: A case-control study nested within the European Prospective Investigation into Cancer and Nutrition cohort to examine associations among premenopausal serum concentrations of sex steroids and subsequent breast cancer risk found no statistically significant association with serum levels.
References
More filters
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal ArticleDOI
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
Eugenia E. Calle,Clark W. Heath,R. J. Coates,Jonathan M. Liff,Silvia Franceschi,R. Talamini,N. Chantarakul,Suporn Koetsawang,D. Rachawat,A. Morabia,L. Schuman,Walter F. Stewart,Moyses Szklo,Chris Bain,F. Schofield,Victor Siskind,Philip A. Band,Andrew J. Coldman,Richard P. Gallagher,T. G. Hislop,P. Yang,Stephen W. Duffy,L. M. Kolonel,A. M.Y. Nomura,Mark W. Oberle,Howard W. Ory,Herbert B. Peterson,Hoyt G. Wilson,Phyllis A. Wingo,K. Ebeling,D. Kunde,P. Nishan,Graham A. Colditz,Nicholas G. Martin,Tieng Pardthaisong,S. Silpisornkosol,C. Theetranont,B. Boosiri,S. Chutivongse,P. Jimakorn,Pramuan Virutamasen,C. Wongsrichanalai,Anthony J. McMichael,T. Rohan,Marianne Ewertz,Carle Paul,David C. G. Skegg,G. F. S. Spears,P. Boyle,M. Evstifeeva,J. R. Daling,W. B. Hutchinson,Kathi Malone,E. A. Noonan,Janet L. Stanford,David B. Thomas,N. S. Weiss,Emily White,N. Andrieu,A. Bràmond,F Clavel,B. Gairard,J. Lansac,L. Piana,R. Renaud,S. R.P. Fine,H. R. Cuevas,P. Ontiveros,A. Palet,S. B. Salazar,N. Aristizabel,A. Cuadros,A. Bachelot,M. G. Lê,J. Deacon,Julian Peto,C. N. Taylor,E. Alfandary,Baruch Modan,Elaine Ron,Gary D. Friedman,Robert A. Hiatt,T. Bishop,J. Kosmelj,M. Primic-Zakelj,B. Ravnihar,J. Stare,W. L. Beeson,Graeme Fraser,R. D. Bulbrook,Jack Cuzick,I. S. Fentiman,J. L. Hayward,De Yun Wang,R. L. Hanson,M. C. Leske,Martin C. Mahoney,P. C. Nasca,A. O. Varma,A. L. Weinstein,Torgil Möller,Håkan Olsson,Jonas Ranstam,R.A. Goldbohm,P.A. van den Brandt,R. A. Apelo,J. Baens,J. R. de la Cruz,B. Javier,L. B. Lacaya,Corazon A. Ngelangel,C. La Vecchia,E. Negri,Ettore Marubini,Monica Ferraroni,Mariette Gerber,Sylvia Richardson,C. Segala,D. Gatei,P. Kenya,A. Kungu,J. G. Mati,L A Brinton,Robert N. Hoover,Catherine Schairer,Robert Spirtas,H. P. Lee,Matti A. Rookus,F.E. van Leeuwen,J. A. Schoenberg,Marilie D. Gammon,E. A. Clarke,Lee W. Jones,Klim McPherson,A. Neil,M. Vessey,D. Yeates,Valerie Beral,Diana Bull,B. Crossley,C Hermon,Simon Jones,Timothy J. Key,Claire E. Lewis,Gillian K Reeves,Rory Collins,Richard Doll,Richard Peto,P. Hannaford,Kay Cr,Luis Rosero-Bixby,Jian-Min Yuan,H. Y. Wei,T. Yun,C. Zhiheng,G. Berry,J Cooper Booth,T. Jelihovsky,Robert MacLennan,R. Shearman,Q. S. Wang,C. J. Baines,Anthony B. Miller,C. Wall,Eiliv Lund,H. Stalsberg,A. Dabancens,L. Martinez,R. Molina,O. Salas,Freda E. Alexander,B. S. Hulka,C. E. D. Chilvers,Leslie Bernstein,Robert W. Haile,Annlia Paganini-Hill,M. C. Pike,R. K. Ross,Giske Ursin,Mimi C. Yu,M. P. Longnecker,Polly A. Newcomb,T. M.N. Farley,S. Holck,O. Meirik,Hans-Olov Adami,R. Bergkvist,Ingemar Persson,Fabio Levi,Kiyohiko Mabuchi,Dale L. Preston,Klea Katsouyanni,Antonia Trichopoulou,D. Trichopoulos,Leif Bergkvist +194 more
TL;DR: Of the many factors examined that might affect the relation between breast cancer risk and use of HRT, only a woman's weight and body-mass index had a material effect: the increase in the relative risk of breast cancer diagnosed in women using HRT and associated with long durations of use in current and recent users was greater for women of lower than of higher weight or body- mass index.
Journal ArticleDOI
Design of the Women's Health Initiative clinical trial and observational study
Garnet L. Anderson,S. Cummings,L. S. Freedman,C. Furberg,Maureen M. Henderson,Susan R. Johnson,L. Kuller,JoAnn E. Manson,A. Oberman,Ross L. Prentice,Jacques E. Rossouw,L. Finnegan,R. Hiatt,L. Pottern,J. McGowan,C. Clifford,B. Caan,V. Kipnis,B. Ettinger,S. Sidney,G. Bailey,Andrea Z. LaCroix,Anne McTiernan,Deborah J. Bowen,C. Chen,Barbara B. Cochrane,Julie R. Hunt,Alan R. Kristal,Brian J. Lund,Ruth E. Patterson,Jeffrey L. Probstfield,Lesley F. Tinker,Nicole Urban,Ching Yun Wang,Emily White,J. M. Kotchen,S. Shumaker,P. Rautaharju,F. Rautaharju,E. Stein,P. Laskarzewski,P. Steiner,K. Sagar,M. Nevitt,M. Dockrell,T. Fuerst,John H. Himes,M. Stevens,F. Cammarata,S. Lindenfelser,Bruce M. Psaty,D. Siscovick,W. Longstreth,S. Heckbert,S. Wassertheil-Smoller,W. Frishman,Judy Wylie-Rosett,D. Barad,R. Freeman,S. Miller,Jennifer Hays,R. Young,C. Crowley,M. A. DePoe,G. Burke,E. Paskett,L. Wagenknecht,R. Crouse,L. Parsons,T. Kotchen,E. Braunwald,J. Buring,C. Hennekens,J. M. Gaziano,Annlouise R. Assaf,R. C. Carleton,M. Miller,C. Wheeler,A. Hume,M. Pedersen,O. Strickland,M. Huber,V. Porter,Shirley A.A. Beresford,V. Taylor,N. Woods,J. Hsia,V. Barnabei,M. Bovun,Rowan T. Chlebowski,R. Detrano,A. Nelson,J. Heiner,S. Pushkin,B. Valanis,V. Stevens,E. Whitlock,N. Karanja,A. Clark +98 more
TL;DR: The rationale for the interventions being studied in each of the CT components and for the inclusion of the OS component is described, including a brief description of the scientific and logistic complexity of the WHI.
Journal ArticleDOI
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Graham A. Colditz,Susan E. Hankinson,David J. Hunter,Walter C. Willett,JoAnn E. Manson,Meir J. Stampfer,Charles H. Hennekens,Bernard Rosner,Frank E. Speizer +8 more
TL;DR: In this paper, the effect of adding progestins to estrogen therapy on the risk of breast cancer in postmenopausal women is investigated. But, the effect on the number of newly diagnosed invasive breast cancer cases was not quantified.
Journal ArticleDOI
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Patricia A. Carney,Diana L. Miglioretti,Bonnie C. Yankaskas,Karla Kerlikowske,Robert D. Rosenberg,Carolyn M. Rutter,Berta M. Geller,Linn Abraham,Steven H. Taplin,Mark Dignan,Gary Cutter,Rachel Ballard-Barbash +11 more
TL;DR: The accuracy of screening mammography is best in older women and in women with fatty breasts, and the individual and combined effects of age, breast density, and HRT use on mammographic accuracy are examined.
Related Papers (5)
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
Garnet L. Anderson,Marian C. Limacher,Annlouise R. Assaf,Tamsen Bassford,Shirley A.A. Beresford,Henry R. Black,Denise E. Bonds,Robert L. Brunner,Robert G. Brzyski,Bette J. Caan,Rowan T. Chlebowski,J. David Curb,Margery Gass,Jennifer Hays,Gerardo Heiss,Susan L. Hendrix,Barbara V. Howard,Judith Hsia,F. Allan Hubbell,Rebecca D. Jackson,Karen C. Johnson,Howard L. Judd,Jane Morley Kotchen,Lewis H. Kuller,Andrea Z. LaCroix,Dorothy S. Lane,Robert Langer,Norman L. Lasser,Cora E. Lewis,JoAnn E. Manson,Karen L. Margolis,Judith K. Ockene,Mary Jo O'Sullivan,Lawrence S. Phillips,Ross L. Prentice,Cheryl Ritenbaugh,John A Robbins,Jacques E. Rossouw,Gloria E. Sarto,Marcia L. Stefanick,Linda Van Horn,Jean Wactawski-Wende,Robert B. Wallace,Sylvia Wassertheil-Smoller +43 more
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
Eugenia E. Calle,Clark W. Heath,R. J. Coates,Jonathan M. Liff,Silvia Franceschi,R. Talamini,N. Chantarakul,Suporn Koetsawang,D. Rachawat,A. Morabia,L. Schuman,Walter F. Stewart,Moyses Szklo,Chris Bain,F. Schofield,Victor Siskind,Philip A. Band,Andrew J. Coldman,Richard P. Gallagher,T. G. Hislop,P. Yang,Stephen W. Duffy,L. M. Kolonel,A. M.Y. Nomura,Mark W. Oberle,Howard W. Ory,Herbert B. Peterson,Hoyt G. Wilson,Phyllis A. Wingo,K. Ebeling,D. Kunde,P. Nishan,Graham A. Colditz,Nicholas G. Martin,Tieng Pardthaisong,S. Silpisornkosol,C. Theetranont,B. Boosiri,S. Chutivongse,P. Jimakorn,Pramuan Virutamasen,C. Wongsrichanalai,Anthony J. McMichael,T. Rohan,Marianne Ewertz,Carle Paul,David C. G. Skegg,G. F. S. Spears,P. Boyle,M. Evstifeeva,J. R. Daling,W. B. Hutchinson,Kathi Malone,E. A. Noonan,Janet L. Stanford,David B. Thomas,N. S. Weiss,Emily White,N. Andrieu,A. Bràmond,F Clavel,B. Gairard,J. Lansac,L. Piana,R. Renaud,S. R.P. Fine,H. R. Cuevas,P. Ontiveros,A. Palet,S. B. Salazar,N. Aristizabel,A. Cuadros,A. Bachelot,M. G. Lê,J. Deacon,Julian Peto,C. N. Taylor,E. Alfandary,Baruch Modan,Elaine Ron,Gary D. Friedman,Robert A. Hiatt,T. Bishop,J. Kosmelj,M. Primic-Zakelj,B. Ravnihar,J. Stare,W. L. Beeson,Graeme Fraser,R. D. Bulbrook,Jack Cuzick,I. S. Fentiman,J. L. Hayward,De Yun Wang,R. L. Hanson,M. C. Leske,Martin C. Mahoney,P. C. Nasca,A. O. Varma,A. L. Weinstein,Torgil Möller,Håkan Olsson,Jonas Ranstam,R.A. Goldbohm,P.A. van den Brandt,R. A. Apelo,J. Baens,J. R. de la Cruz,B. Javier,L. B. Lacaya,Corazon A. Ngelangel,C. La Vecchia,E. Negri,Ettore Marubini,Monica Ferraroni,Mariette Gerber,Sylvia Richardson,C. Segala,D. Gatei,P. Kenya,A. Kungu,J. G. Mati,L A Brinton,Robert N. Hoover,Catherine Schairer,Robert Spirtas,H. P. Lee,Matti A. Rookus,F.E. van Leeuwen,J. A. Schoenberg,Marilie D. Gammon,E. A. Clarke,Lee W. Jones,Klim McPherson,A. Neil,M. Vessey,D. Yeates,Valerie Beral,Diana Bull,B. Crossley,C Hermon,Simon Jones,Timothy J. Key,Claire E. Lewis,Gillian K Reeves,Rory Collins,Richard Doll,Richard Peto,P. Hannaford,Kay Cr,Luis Rosero-Bixby,Jian-Min Yuan,H. Y. Wei,T. Yun,C. Zhiheng,G. Berry,J Cooper Booth,T. Jelihovsky,Robert MacLennan,R. Shearman,Q. S. Wang,C. J. Baines,Anthony B. Miller,C. Wall,Eiliv Lund,H. Stalsberg,A. Dabancens,L. Martinez,R. Molina,O. Salas,Freda E. Alexander,B. S. Hulka,C. E. D. Chilvers,Leslie Bernstein,Robert W. Haile,Annlia Paganini-Hill,M. C. Pike,R. K. Ross,Giske Ursin,Mimi C. Yu,M. P. Longnecker,Polly A. Newcomb,T. M.N. Farley,S. Holck,O. Meirik,Hans-Olov Adami,R. Bergkvist,Ingemar Persson,Fabio Levi,Kiyohiko Mabuchi,Dale L. Preston,Klea Katsouyanni,Antonia Trichopoulou,D. Trichopoulos,Leif Bergkvist +194 more